Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News St Jude Medical commences enrolment for Ilumien I artery stent trial

St Jude Medical commences enrolment for Ilumien I artery stent trial

21st December 2012

St Jude Medical has announced the commencement of patient enrolment for a new study assessing the benefits of a new method of stent-based treatment for coronary artery disease.

The first patient has been enrolled for the observational Ilumien I trial, which has been designed to show the optimal way Optical Coherence Tomography, combined with the St Jude Medical PressureWire Aeris wireless interventional tool, can guide stent implantation in patients with coronary artery disease.

It will observe and record how physicians treat patients while undergoing percutaneous coronary interventions, while also measuring outcomes according to various procedural parameter, with the aim of producing guidance parameters for optimal stenting in future.

Frank Callaghan, president of the cardiovascular and ablation technology division at St Jude Medical, said: "We are confident that the Ilumien I study will result in establishing more efficient lab procedures for physicians and better treatment plans for patients."

Earlier this month, the company was granted European CE Mark for its new Assura portfolio of implantable cardioverter defibrillators and cardiac resynchronisation therapy defibrillators.ADNFCR-8000103-ID-801511340-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.